Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

A rare autoimmune disease caused the woman's scalp blisters and hair loss, successfully treated with medication.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

A new method improves alopecia diagnosis using non-invasive steps.

A rare type of skin cancer on the scalp can be mistaken for hair loss, causing delayed diagnosis and severe damage.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

Early hair loss may predict heart disease.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Hair transplants can work for stable cicatricial alopecia, but success varies by condition.

Current treatments for neutrophilic alopecias in children are limited and often ineffective, especially for males and those of Afro-Caribbean descent.

Disease-specific tools better assess quality of life in alopecia areata patients.

Alopecia areata significantly affects patients' lives, causing physical, psychological, social, and financial challenges.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

IFAP syndrome is a rare genetic disorder causing skin, hair, and eye issues, with limited treatment options.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

An elderly man's hair grew back after a treatment that transferred healthy gut bacteria.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Scalp cooling effectively reduces hair loss in breast cancer patients undergoing chemotherapy.

New digital tools are improving the diagnosis and understanding of irreversible hair loss conditions.

Oral isotretinoin temporarily improved skin symptoms in a child with IFAP syndrome.

Some drugs can cause permanent hair loss, though it's rare.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Hair extensions can worsen scalp conditions and should be avoided in those with alopecia.